全文获取类型
收费全文 | 2602357篇 |
免费 | 204941篇 |
国内免费 | 6342篇 |
专业分类
耳鼻咽喉 | 34920篇 |
儿科学 | 86296篇 |
妇产科学 | 73119篇 |
基础医学 | 375932篇 |
口腔科学 | 75029篇 |
临床医学 | 242527篇 |
内科学 | 501150篇 |
皮肤病学 | 54306篇 |
神经病学 | 214009篇 |
特种医学 | 99430篇 |
外国民族医学 | 804篇 |
外科学 | 379057篇 |
综合类 | 62547篇 |
现状与发展 | 4篇 |
一般理论 | 973篇 |
预防医学 | 213607篇 |
眼科学 | 59130篇 |
药学 | 194984篇 |
10篇 | |
中国医学 | 5435篇 |
肿瘤学 | 140371篇 |
出版年
2018年 | 27538篇 |
2017年 | 21147篇 |
2016年 | 23307篇 |
2015年 | 26778篇 |
2014年 | 36901篇 |
2013年 | 56968篇 |
2012年 | 77558篇 |
2011年 | 82258篇 |
2010年 | 48262篇 |
2009年 | 45296篇 |
2008年 | 76923篇 |
2007年 | 81199篇 |
2006年 | 81793篇 |
2005年 | 79432篇 |
2004年 | 77040篇 |
2003年 | 73472篇 |
2002年 | 71773篇 |
2001年 | 117187篇 |
2000年 | 121078篇 |
1999年 | 102251篇 |
1998年 | 28942篇 |
1997年 | 26298篇 |
1996年 | 26024篇 |
1995年 | 25148篇 |
1994年 | 23625篇 |
1993年 | 22307篇 |
1992年 | 83525篇 |
1991年 | 81729篇 |
1990年 | 79533篇 |
1989年 | 76411篇 |
1988年 | 71062篇 |
1987年 | 69732篇 |
1986年 | 66499篇 |
1985年 | 64024篇 |
1984年 | 48134篇 |
1983年 | 41368篇 |
1982年 | 24736篇 |
1981年 | 22026篇 |
1979年 | 45169篇 |
1978年 | 31743篇 |
1977年 | 26584篇 |
1976年 | 25374篇 |
1975年 | 26604篇 |
1974年 | 32514篇 |
1973年 | 31488篇 |
1972年 | 28985篇 |
1971年 | 27222篇 |
1970年 | 25074篇 |
1969年 | 23290篇 |
1968年 | 21781篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression 总被引:2,自引:0,他引:2
Two patients with sideroblastic anemia secondary to zinc-induced copper deficiency absorbed excess zinc secondary to oral ingestion. The source of excess zinc was a zinc supplement in one case; in the other, ingested coins. In each case, the sideroblastic anemia was corrected promptly after removal of the source of excess zinc. These two cases emphasize the importance of recognizing this clinical entity, since the myelodysplastic features are completely reversible. 相似文献
992.
993.
E R Wald 《The Journal of family practice》1988,26(4):367-368
994.
995.
Oil-emulsified (OE) and aqueous (Aq) vaccines were prepared with the same batch of inactivated A24 8345 foot and mouth disease virus (FMDV). Calves born to vaccinated dams did not respond to the Aq vaccine 30 or 90 days post partum. When the OE vaccine was used on a similar group of calves, no responses were elicited up to 21 days post partum. However, calves 30 or more days old responded like adult cattle to the OE vaccine. When the OE vaccine was used in colostral antibody-free calves 3-30 days old, all animals showed good antibody responses but, in calves vaccinated 3 or 7 days post partum, antibodies were detectable only after a considerable period of time. Our results show that both passively acquired colostral antibodies and age are important in the response of very young calves to FMDV oil vaccines. From a practical point of view, in endemic areas where adult cattle are periodically vaccinated, vaccination of calves between 30 and 60 days post partum with OE vaccines would lead to high levels of herd protection. 相似文献
996.
Relation between energy expenditure and body composition in man: specific energy expenditure in vivo of fat and fat-free tissue 总被引:2,自引:0,他引:2
L Garby J S Garrow B J?rgensen O Lammert K Madsen P S?rensen J Webster 《European journal of clinical nutrition》1988,42(4):301-305
The relationship between energy expenditure and body composition, in terms of fat and fat-free masses, has previously been described by a variety of predictive regression equations with parameters devoid of physiological content. We present here results obtained by calculating the specific energy expenditure, ie, the energy expenditure per unit of mass, of fat and fat-free tissue on the basis of measurements of the total energy expenditure (EE), the masses of fat (FM), and fat-free (FFM) tissue using the following simple model: EE = k1.FM + k2.FFM where k1 and k2 are the specific energy expenditures of fat and fat-free tissue, respectively. The results of observations on 104 women at rest yielded values for k1 and k2 of 0.31 and 1.35 watts/kg of fat and fat-free mass, respectively, with standard errors of estimate of 0.074 and 0.052 watts/kg, respectively. Analysis of several series of measurements, from other sources and on smaller samples of subjects, yielded similar values at rest but with larger standard errors of estimate. Data from subjects performing varying amounts of work in 24-h measurements showed, as expected, larger values for both tissues. The results explain to a very large extent the well-established relation between resting metabolic rate and body weight, ie, a linear relation with a non-zero intercept. The results also offer a clear-cut explanation for the well known difference in energy expenditure between men and women with the same body weight. 相似文献
997.
Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors 总被引:1,自引:0,他引:1
Ninety-nine patients with primary recurrent malignant tumors of the central nervous system were treated with procarbazine as a single agent. Procarbazine was not given as a specified protocol, but for patients who were ineligible or refused other protocols. All patients had been treated previously with radiotherapy and 96 patients had also received previous chemotherapy. Twenty-five patients were treated at the first progression of their tumor, 47 were treated at the second progression, and 27 were treated at the third progression of their tumor. For the aggregate, the response plus stabilization rate was 27% for glioblastoma multiforme with median time to tumor progression of 30 weeks, and 28% for other anaplastic gliomas with a median time to tumor progression of 49 weeks. With respect to the percent of patients who responded or stabilized to treatment, these results are inferior to those reported previously for patients treated with procarbazine at recurrence. With respect to duration of response and stabilization, the data are comparable. 相似文献
998.
R. P. Heaney T. M. Zizic I. Fogelman W. P. Olszynski P. Geusens C. Kasibhatla N. Alsayed G. Isaia M. W. Davie C. H. Chesnut III 《Osteoporosis international》2002,13(6):501-505
Risedronate treatment reduces the risk of vertebral fracture in women with existing vertebral fractures, but its efficacy
in prevention of the first vertebral fracture in women with osteoporosis but without vertebral fractures has not been determined.
We examined the risk of first vertebral fracture in postmenopausal women who were enrolled in four placebo-controlled clinical
trials of risedronate and who had low lumbar spine bone mineral density (BMD) (mean T-score =–3.3) and no vertebral fractures at baseline. Subjects received risedronate 5 mg (n= 328) or placebo (n= 312) daily for up to 3 years; all subjects were given calcium (1000 mg daily), as well as vitamin D supplementation (up
to 500 IU daily) if baseline serum 25-hydroxyvitamin D levels were low. The incidence of first vertebral fracture was 9.4%
in the women treated with placebo and 2.6% in those treated with risedronate 5 mg (risk reduction of 75%, 95% confidence interval
37% to 90%; P= 0.002). The number of patients who would need to be treated to prevent one new vertebral fracture is 15. When subjects were
stratified by age, similar significant reductions were observed in patients with a mean age of 64 years (risk reduction of
70%, 95% CI 8% to 90%; P= 0.030) and in those with a mean age of 76 years (risk reduction of 80%, 95% CI 7% to 96%; P= 0.024). Risedronate treatment therefore significantly reduces the risk of first vertebral fracture in postmenopausal women
with osteoporosis, with a similar magnitude of effect early and late after the menopause.
Received: 12 September 2001 / Accepted: 11 December 2001 相似文献
999.
Effect of nedocromil on bronchospasm induced by inhalation of substance P in asthmatic subjects 总被引:3,自引:0,他引:3
N Crimi F Palermo R Oliveri B Palermo C Vancheri R Polosa A Mistretta 《Clinical allergy》1988,18(4):375-382
Several studies have demonstrated that neuropeptides are present in peptidergic fibres of bronchial tissue. The aim of the present study was to evaluate in vivo the effect of nedocromil sodium (2 x 2 mg) on bronchospasm induced by inhalation of substance P. Six moderate asthmatic patients, mean age 25.17 years, were studied. Airway response was measured as FEV1 and the dose of substance P (using a dose range of 23-736 nmol) producing a 20% decrease in FEV1 (PD20) was calculated from the individual semilogarithmic dose-response curves. Patients were studied on 3 separate days in a randomized, double-blind manner. On the first day a baseline PD20 value was determined. On subsequent days substance P challenge was performed after pretreatment (20 min before challenge) with either placebo or nedocromil sodium. Student's paired t-test and Wilcoxon's test were used for statistical analysis. The results of this study demonstrated that inhalation of substance P causes a dose-dependent bronchoconstriction and that the bronchoconstriction induced by substance P can be prevented by pre-treatment with nedocromil sodium. 相似文献
1000.